Cecchetto G, Luzzatto C, Carli M, Guglielmi M, Zanesco L
Tumori. 1983 Aug 31;69(4):327-9. doi: 10.1177/030089168306900409.
The authors considered 59 stage III and IV neuroblastoma cases, which were observed from January 1967 to June 1979. 13 patients (13/59 = 22%) are surviving in complete remission 3 years after surgery: 9/20 (45%) with stage III and 4/39 (10%) with stage IV disease. The children subjected to complete surgical excision are all alive irregardless of age; the children who were not operated on or subjected to a biopsy, have all died. Of the 33 patients who underwent a reductive excision, 6 (all under 2 years of age) are in complete remission (18%). A better prognosis was found in those patients in whom the site of the primary tumor was at the mediastinal level. These data show the importance of the role of the surgeon in the multidisciplinary treatment of stage III and IV neuroblastomas; our experience is also favorable to the practice of second-look surgery.
作者对1967年1月至1979年6月期间观察到的59例III期和IV期神经母细胞瘤病例进行了研究。13例患者(13/59 = 22%)在手术后3年处于完全缓解状态存活:III期患者9/20(45%),IV期患者4/39(10%)。接受完全手术切除的儿童无论年龄大小均存活;未接受手术或活检的儿童均已死亡。在接受减瘤切除的33例患者中,6例(均为2岁以下)处于完全缓解状态(18%)。发现原发肿瘤位于纵隔水平的患者预后较好。这些数据表明了外科医生在III期和IV期神经母细胞瘤多学科治疗中的重要作用;我们的经验也支持二次探查手术的做法。